
Biotechnology
Innovations in cancer immunotherapy: Bi-specific T cell engagers
Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
Trupti has a Ph.D. in Cell Biology from the Indian Institute of Science Education and Research (IISER), Pune. She previously gained extensive experience in scientific writing, data curation, and analysis in diverse fields like pharmaceuticals, medical devices, and precision oncology. She combines her deep domain knowledge with scientific reasoning skills to transform complex data into actionable insights.





